Descriptive study reveals 50.5% prevalence of CIM use in pediatric oncology, highlighting communication gaps with medical teams.
The use of complementary and integrative medicine (CIM) has increased in pediatric oncology care, aiming to improve quality of life and mitigate the adverse effects of conventional treatments. This descriptive study aims to evaluate the prevalence and demographic characteristics of pediatric oncology patients using CIM in Chile. An anonymous survey was conducted among parents of patients undergoing oncology treatment, analyzing 107 valid responses. The results show a prevalence of 50.5% in the use of CIM, with limited communication between patients and medical teams regarding these practices. It is concluded that greater education and communication between healthcare professionals and patients about the use of CIM are necessary.
No takes yet. Share an insight, caveat, or question.
Roberto et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: